Skip to main content
INTCO MEDICAL TECHNOLOGY CO., LTD. logo

INTCO MEDICAL TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 300677 ISIN · CNE100003456 LEI · 549300U6H4L6SSU31U28 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,902 across all filing types
Latest filing 2026-04-23 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300677

About INTCO MEDICAL TECHNOLOGY CO., LTD.

https://www.intcomedical.com.cn

INTCO Medical Technology Co., Ltd. is a high-tech manufacturer specializing in the research, development, production, and marketing of medical consumables and durable medical equipment. The company's primary product portfolio includes a wide range of disposable medical gloves, such as nitrile, vinyl, and latex varieties, which serve as critical protective gear in healthcare and industrial settings. Beyond consumables, the firm produces durable medical equipment including manual and electric wheelchairs, hospital beds, and patient mobility aids. It also offers physical therapy products like cold and hot packs and various medical electrodes. With a focus on large-scale production and advanced manufacturing technology, the company serves a global clientele across healthcare, laboratory, and food service sectors. Its operations emphasize quality control and compliance with international standards to ensure product safety and reliability.

Recent filings

Filing Released Lang Actions
董事、高级管理人员薪酬管理制度
Governance Information Classification · 85% confidence The text is an internal corporate policy titled “Board and Senior Management Compensation Management System” for 英科医疗科技股份有限公司, detailing principles, processes, and oversight of director and senior management remuneration. It is not a financial report, proxy statement, or transaction announcement but a governance rulebook on compensation. This aligns with Governance Information (CGR).
2026-04-23 Chinese
关于部分会计政策变更的公告
Regulatory Filings Classification · 90% confidence The document is an official announcement (公告) by a listed company disclosing changes in accounting policies mandated by the Ministry of Finance. It is not a full financial report (10-K or IR), not an audit opinion (AR), nor a notice of dividends, voting, M&A, or other transactional or operational items. Instead, it is a regulatory disclosure required under exchange listing rules. This fits the fallback “Regulatory Filings” category (RNS).
2026-04-23 Chinese
关于开展外汇衍生品交易业务的可行性分析报告
Regulatory Filings Classification · 75% confidence The document is a detailed feasibility analysis and risk management plan for engaging in foreign exchange derivatives trading. It is not an AGM presentation (AGM-R), an Annual Report (10-K), an earnings release (ER), or any of the other narrowly defined filings (e.g., share issues, M&A, dividends, etc.). It appears to be a compliance announcement under listing rules regarding proposed derivative activities and internal control measures rather than the actual derivative contracts or a capital raising. This falls into the general category of regulatory or compliance filings that do not fit the other specific categories. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-04-23 Chinese
第四届董事会第十四次（定期）会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 14th regular meeting of the 4th Board of Directors of Yingke Medical Technology Co., Ltd. It includes approvals of various reports such as the 2025 Board Work Report, 2025 General Manager Work Report, 2025 Annual Report and its summary, 2026 Q1 Report, 2025 ESG Report, 2025 Internal Control Evaluation Report, and other governance and operational matters. The document repeatedly references that the actual reports are published separately on the official information disclosure website (cninfo.com.cn) and other announcements with specific announcement numbers. The document is a formal board meeting resolution announcement, not the reports themselves. It also includes items that require shareholder meeting approval. The document is not a full annual report or interim report but a board meeting resolution announcement covering multiple governance and management topics. Therefore, the best fitting category is Board/Management Information (MANG).
2026-04-23 Chinese
2026年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "英科医疗科技股份有限公司2026年第一季度报告" which translates to "Yingke Medical Technology Co., Ltd. 2026 First Quarter Report." It contains detailed financial data including balance sheets, income statements, cash flow statements, and shareholder information for the first quarter of 2026. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the quarter. It also mentions that the report is unaudited. The length of the document (13,959 characters) and the detailed financial content confirm it is a full interim/quarterly financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-23 Chinese
2025年年度审计报告
Regulatory Filings
2026-04-23 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.